Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareCloud (CCLD) Research & Development (2016 - 2025)

CareCloud (CCLD) has disclosed Research & Development for 13 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development rose 98.0% to $1.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.9 million, a 21.88% increase, with the full-year FY2024 number at $3.8 million, down 20.16% from a year prior.
  • Research & Development was $1.6 million for Q3 2025 at CareCloud, up from $1.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $5.9 million in Q4 2022 to a low of $488000.0 in Q3 2021.
  • A 5-year average of $1.5 million and a median of $1.2 million in 2022 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: skyrocketed 139.34% in 2022, then tumbled 79.61% in 2023.
  • CareCloud's Research & Development stood at $3.3 million in 2021, then surged by 81.82% to $5.9 million in 2022, then tumbled by 79.61% to $1.2 million in 2023, then fell by 16.49% to $1.0 million in 2024, then soared by 56.37% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for CCLD's Research & Development are $1.6 million (Q3 2025), $1.0 million (Q2 2025), and $1.2 million (Q1 2025).